​

Zynex (ZYXI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZYXI Stock Forecast

Zynex (ZYXI) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $14.38, with a high of $18.00 and a low of $11.00. This represents a 957.35% increase from the last price of $1.36.

- $4 $8 $12 $16 $20 High: $18 Avg: $14.38 Low: $11 Last Closed Price: $1.36

ZYXI Stock Rating

Zynex stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (66.67%), 3 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 3 6 0 Strong Sell Sell Hold Buy Strong Buy

ZYXI Price Target Upside V Benchmarks

TypeNameUpside
StockZynex957.35%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks8.54%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.36$1.36$1.36
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-12--3
Sep, 25-12--3
Aug, 25112--4
Jul, 251-2--3
Jun, 251-2--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2024Shagun SinghRBC Capital$11.00$7.7841.39%708.82%
Sep 17, 2024Owen RickertNorthland Securities$12.50$8.2751.15%819.12%
Jul 26, 2024Yi ChenH.C. Wainwright$16.00$8.3890.93%1076.47%
Jun 14, 2024Shagun SinghRBC Capital$15.00$8.9867.04%1002.94%
Jan 06, 2023Piper Sandler$18.00$14.1427.30%1223.53%
Apr 28, 2022Adam MaederPiper Sandler$7.00$7.14-1.96%414.71%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 15, 2025RBC CapitalSector PerformSector Performhold
Mar 12, 2025RBC CapitalOutperformSector Performdowngrade
Oct 08, 2024RBC CapitalOutperformOutperformhold
Sep 05, 2024H.C. WainwrightBuyBuyhold
Jul 26, 2024H.C. WainwrightBuyBuyhold
Jun 14, 2024RBC CapitalOutperformOutperformhold
Jan 06, 2023Sandler O'NeillOverweightupgrade
Jan 06, 2023Piper SandlerNeutralOverweightupgrade
Apr 28, 2022Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.24$0.41$0.44$0.27$0.09----
Avg Forecast$0.25$0.42$0.43$0.41$0.20$0.48$0.87$1.20$1.65
High Forecast$0.25$0.42$0.43$0.42$0.20$0.50$0.92$1.21$1.66
Low Forecast$0.24$0.42$0.42$0.40$0.19$0.46$0.82$1.19$1.64
Surprise %-4.00%-2.38%2.33%-34.15%-55.00%----

Revenue Forecast

$50M $130M $210M $290M $370M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$80.12M$130.30M$158.17M$184.32M$192.35M----
Avg Forecast$80.33M$131.25M$159.09M$191.63M$200.03M$239.60M$289.65M$344.50M$409.20M
High Forecast$80.62M$131.73M$159.47M$192.27M$200.70M$240.40M$290.61M$345.65M$410.56M
Low Forecast$80.14M$130.95M$158.33M$190.36M$198.70M$238.01M$287.72M$342.21M$406.48M
Surprise %-0.25%-0.72%-0.58%-3.81%-3.84%----

Net Income Forecast

$0 $12M $24M $36M $48M $60M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.07M$17.10M$17.05M$9.73M$2.99M----
Avg Forecast$8.32M$13.25M$17.35M$9.73M$7.07M$17.23M$31.44M$43.28M$59.63M
High Forecast$9.98M$16.28M$20.82M$11.68M$7.26M$17.96M$33.25M$43.56M$59.89M
Low Forecast$6.65M$10.23M$13.88M$7.79M$6.88M$16.49M$29.64M$43.00M$59.12M
Surprise %9.10%29.05%-1.74%--57.66%----

ZYXI Forecast FAQ

Is Zynex stock a buy?

Zynex stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zynex is a favorable investment for most analysts.

What is Zynex's price target?

Zynex's price target, set by 9 Wall Street analysts, averages $14.38 over the next 12 months. The price target range spans from $11 at the low end to $18 at the high end, suggesting a potential 957.35% change from the previous closing price of $1.36.

How does Zynex stock forecast compare to its benchmarks?

Zynex's stock forecast shows a 957.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical distribution stocks industry (8.54%).

What is the breakdown of analyst ratings for Zynex over the past three months?

  • October 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Zynex’s EPS forecast?

Zynex's average annual EPS forecast for its fiscal year ending in December 2025 is $0.48, marking a 433.33% increase from the reported $0.09 in 2024. Estimates for the following years are $0.87 in 2026, $1.2 in 2027, and $1.65 in 2028.

What is Zynex’s revenue forecast?

Zynex's average annual revenue forecast for its fiscal year ending in December 2025 is $239.6M, reflecting a 24.56% increase from the reported $192.35M in 2024. The forecast for 2026 is $289.65M, followed by $344.5M for 2027, and $409.2M for 2028.

What is Zynex’s net income forecast?

Zynex's net income forecast for the fiscal year ending in December 2025 stands at $17.23M, representing an 475.41% increase from the reported $2.99M in 2024. Projections indicate $31.44M in 2026, $43.28M in 2027, and $59.63M in 2028.